Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Edelman

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Human Vaccines|October 12, 2010
Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areasG William Letson, Pratap Singhasivanon, Eduardo Fernandez, et al.
Trends in Immunology|June 23, 2009
Vaccination in the elderly: an immunological perspectiveWilbur H Chen, Bernard F Kozlovsky, Rita B Effros, et al.
Vaccine|March 1, 2011
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccineWilbur H Chen, Alan S Cross, Robert Edelman, et al.
Plos One|February 7, 2008
Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite proteinAric L Gregson, Giane Oliveira, Caroline Othoro, et al.
BMC Infectious Diseases|December 5, 2002
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in EgyptMalla R Rao, Abdollah B Naficy, Medhat A Darwish, et al.
The Journal of Infectious Diseases|July 12, 2011
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidateKathryn B Anderson, Robert V Gibbons, Robert Edelman, et al.
Vaccine|April 11, 2013
Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation, Adwoa D Bentsi-Enchill, Julia Schmitz, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteersThomas C Dowling, Pierre A Chavaillaz, David G Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adultsSamer S El-Kamary, Melissa Billington, Stephen Deitz, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|September 28, 2011
Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activationHrushikesh M Joshi, Yen Po Lin, Mohammed Aslam, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Human Vaccines|October 12, 2010
Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areasG William Letson, Pratap Singhasivanon, Eduardo Fernandez, et al.
Trends in Immunology|June 23, 2009
Vaccination in the elderly: an immunological perspectiveWilbur H Chen, Bernard F Kozlovsky, Rita B Effros, et al.
Vaccine|March 1, 2011
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccineWilbur H Chen, Alan S Cross, Robert Edelman, et al.
Plos One|February 7, 2008
Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite proteinAric L Gregson, Giane Oliveira, Caroline Othoro, et al.
BMC Infectious Diseases|December 5, 2002
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in EgyptMalla R Rao, Abdollah B Naficy, Medhat A Darwish, et al.
The Journal of Infectious Diseases|July 12, 2011
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidateKathryn B Anderson, Robert V Gibbons, Robert Edelman, et al.
Vaccine|April 11, 2013
Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation, Adwoa D Bentsi-Enchill, Julia Schmitz, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteersThomas C Dowling, Pierre A Chavaillaz, David G Young, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adultsSamer S El-Kamary, Melissa Billington, Stephen Deitz, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|September 28, 2011
Effects of shape and size of cobalt ferrite nanostructures on their MRI contrast and thermal activationHrushikesh M Joshi, Yen Po Lin, Mohammed Aslam, et al.
Pageof 6